Back to search

Article

Gene-specific response to MuSK agonist antibody in the treatment of Congenital Myasthenic Syndromes

2025-08-30

Abstract excerpt

Congenital myasthenic syndromes (CMS) are a group of rare disorders characterized by fatigable muscle weakness and caused by impaired neuromuscular junction (NMJ) function. CMS symptoms are highly variable, but can be detrimental and lead to death. There are over 40 different genetic subtypes, including Agrn- CMS and ColQ- CMS. Agrn encodes for neural AGRIN, which is released from the nerve terminal and trigger...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5878781f-fdcd-5c0d-9c23-de6f56d2fec8
DOI
10.1101/2025.08.29.673058
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gene-specific response to MuSK agonist antibody in the treatment of Congenital Myasthenic SyndromesDOI 10.1101/2025.08.29.673058
Select a neighboring publication to make it the new centre.